Status: Recruiting
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
This is a Phase 1, open-label, single ascending dose (SAD) and multiple dose (MD) study of AIR-001 in participants with alpha-1 antitrypsin deficiency (AATD) due to PiZZ genotype.
Participants needed: 54
Trial details
Phase: Phase 1Age: 18-74Biological sex: AllType: InterventionalSponsor: AIRNA CorporationUpdated: Apr 28, 2026Locations: 4
Eligibility criteria
Male or female participants >18 years and <75 years of age at the time of signin... [+10]
Female participants who are nursing or lactating [+27]